The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC)
Open Access
- 6 April 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (30) , 48922-48929
Abstract
The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC) The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC)Keywords
This publication has 15 references indexed in Scilit:
- Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasisEuropean Journal of Surgical Oncology, 2014
- Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancerLung Cancer, 2014
- Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2013
- Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single InstitutionThe Oncologist, 2011
- Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results DatabaseJournal of Clinical Oncology, 2006
- Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysisLung Cancer, 2005
- Small Cell Lung Carcinoma (SCLC)American Journal of Surgical Pathology, 2002
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trialsThe Lancet, 1998
- Cancer recurrence after resection: T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1990
- Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent DiseaseThe Annals of Thoracic Surgery, 1984